Home > Journals > Minerva Chirurgica > Past Issues > Minerva Chirurgica 2007 August;62(4) > Minerva Chirurgica 2007 August;62(4):249-55

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA CHIRURGICA

A Journal on Surgery


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,115


eTOC

 

REVIEWS  


Minerva Chirurgica 2007 August;62(4):249-55

Copyright © 2007 EDIZIONI MINERVA MEDICA

language: English

Management of locally advanced breast cancer. Mini-review

Franceschini G., Terribile D., Fabbri C., Magno S., D’Alba P., Chiesa F., Di Leone A., Masetti R.

Breast Surgery Unit Sacro Cuore Catholic University Agostino Gemelli Polyclinic, Rome, Italy


PDF  


The term locally advanced breast cancer (LABC) encompasses a heterogeneous group of breast neoplasms; in the last revision of the American Joint Committee on Cancer (AJCC) staging system, all of stage III disease is considered locally advanced. LABC constitutes up to 20% of breast cancer in medically underserved populations in the United States and up to 75% of breast cancers in developing countries. The prognosis depends on tumor size, extent of lymph node involvement, and the presence or absence of an inflammatory component. The clinical management of LABC is complex and should be tailored to the individual patient. However, a multidisciplinary approach is always recommended combining surgery, radiotherapy and systemic therapy (chemotherapy and/or hormone therapy). In this paper, we discuss the possible options in the management of operable (stage IIIA) and inoperable (stage IIIB-IIIC) LABC.

top of page

Publication History

Cite this article as

Corresponding author e-mail